Related Experiment Video
Updated: Jan 9, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Fertility-Sparing Treatments in Patients With Gynecologic Cancers
Murat Erden1, Sahar Rehman, Chien Oh
1Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut; and the Department of Obstetrics and Gynecology, University of Arizona College of Medicine-Phoenix / Banner - University Medical Center Phoenix, Phoenix, Arizona.
Fertility preservation for gynecologic cancer patients is crucial, but referrals are low. Guidelines support fertility-sparing options for early-stage cancers, highlighting the need for standardized care and routine counseling.
Area of Science:
- Gynecologic Oncology
- Reproductive Medicine
- Clinical Guideline Analysis
Background:
- Fertility preservation is vital for reproductive-aged patients diagnosed with gynecologic cancers.
- A significant gap exists between established guidelines and clinical practice regarding fertility preservation referrals.
- This disparity impacts patient reproductive potential and informed decision-making.
Purpose of the Study:
- To compare 28 clinical guidelines on fertility-sparing management for endometrial, cervical, and ovarian cancers.
- To synthesize recommendations into stage-specific pathways to identify consensus, discrepancies, and evidence gaps.
- To provide a framework for standardizing fertility preservation care in gynecologic oncology.
Main Methods:
- Systematic comparison of 28 clinical guidelines addressing fertility-sparing management.
- Review of diagnostic workup, eligibility criteria, surgical techniques, and surveillance protocols.
- Synthesis of recommendations into stage-specific pathways for analysis.
Main Results:
- Broad consensus exists for fertility-sparing treatment in select early-stage endometrial, cervical, and ovarian cancers.
- Recommendations diverge significantly for higher-stage disease and uncommon tumor types.
- Guideline quality is moderate to high, often relying on limited evidence for complex cases.
Conclusions:
- Synthesizing guidelines clarifies areas for practice standardization and identifies needs for prospective research.
- Integrating routine fertility counseling and specialist referrals into care pathways is essential.
- Standardized pathways can improve fertility preservation uptake while ensuring oncologic safety.
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

